The platelet receptor for von Willebrand factor (vWF) showed little co-localization with filamin at the plasma membrane. These studies demonstrate a functionally active complex between SHIP-2, filamin, actin and GPIb-IX-V which may orchestrate the localized hydrolysis of PtdIns(3,4,5)P 3 and thereby regulate cortical and submembraneous actin.
INTRODUCTION
Following vascular injury, platelet adhesion and aggregation mediate the immediate arrest of bleeding; however, in pathological states this response may contribute to arterial blockage leading to cerebrovascular and coronary arterial occlusion. The interaction of the platelet membrane glycoprotein (GP)Ib-IX-V complex with its adhesive ligand, von Willebrand factor (vWF), in the subendothelial matrix initiates platelet adhesion under conditions of rapid blood flow in the arterial circulation. The GPIb-IX-V complex can also bind plasma vWF under conditions of pathological shear stress, leading to platelet aggregation and thrombosis. [1] [2] [3] Following binding of vWF, the GPIb-IX-V complex initiates intracellular signals inducing platelet activation, spreading and activation of the integrin IIb 3 receptor from a low to high affinity state (inside out signalling). The molecular mechanisms regulating vWF-GPIb-IX-V-induced signaling, however, remain to be fully delineated. 4 The GPIb-IX-V complex is composed of four subunits; GPIb disulphide-linked to GPIb , GPV and GPIX. The extracellular N-terminal globular domain of GPIb contains the binding site for vWF. The 96 amino acid cytoplasmic tail of GPIb contains no overt signaling domains, but directly binds the actin binding-protein, filamin 1a, and the signaling adapter protein, 14-3-3 . 5, 6 Filamins are large actin-binding proteins that stabilize submembraneous actin webs and link them to cellular membranes. Filamins promote high angle actin filament branching and thereby actin gelation, although the molecular mechanisms mediating this effect are incompletely understood. Three filamin isoforms A, B and C have been identified, with A and B expressed in platelets. 7 The interaction of filamin with GPIb-IX-V is essential for regulating the shape of resting
For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From platelets, the spreading of activated platelets and the anchoring of the receptor complex to the membrane skeleton. 5, [8] [9] [10] The stabilization of the platelet membrane resulting from the interaction of filamin with GPIb-IX-V may not only prevent platelet membrane deformation under conditions of high fluid shear stress, but also regulates the adhesive function of the receptor complex itself and the ability of the receptor complex to maintain adhesion to vWF under conditions of high shear stress. 10, 11 Following platelet adhesion, vWF binding to GPIb-IX-V induces the cytoskeletal translocation and activation of the p85/p110 form of phosphoinositide 3-kinase (PI 3-kinase). 12 Under shear conditions, PI 3-kinase is essential for vWF-induced calcium release. 13 A potential mechanism for activation of PI 3-kinase via GPIb-IX-V has been demonstrated in studies from our laboratory, which have shown that the p85 subunit of PI 3-kinase forms a complex with both 14-3-3 and the receptor complex. 6 The inositol lipids phosphatidylinositol 4,5 bisphosphate (PtdIns(4,5)P 2 ) and phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P 3 ), play a central role in the regulation of actin polymerisation and thereby cell motility. 14, 15 Many recent studies have demonstrated in motile cells that PtdIns (3, 4, 5 Collectively these studies suggest that SHIP-2 regulates the localized changes in PtdIns(3,4,5)P 3 that instruct submembraneous actin remodelling, membrane ruffling and promote cell adhesion.
As SHIP-2 appears to significantly influence cytoskeletal remodelling, we investigated the localization and expression of SHIP-2 in platelets. Platelets are highly motile cells with a complex cytoskeleton. At early time points in platelets spreading on a VWF matrix, SHIP-2 localized initially to filopodia and the central actin ring, and with filamin and submembraneous actin at lamellipodia. Actin, GPIb-IX-V, SHIP-2 and filamin were shown in complex in the Triton-soluble fraction of platelets, however, following platelet activation the level of this complex decreased significantly. No complex was detected in the detergent extracted actin cytoskeleton of resting or activated platelets, however, immunofluorescence co-localization studies demonstrate SHIP-2 and
For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From filamin colocalized at the submembraneous actin cytoskeleton of activated platelets spreading on a vWF matrix, suggesting the SHIP-2 filamin complex may relocate to the submembraneous actin cytoskeleton upon platelet activation. Collectively these studies provide evidence that SHIP-2 localizes in spreading platelets to sites of active actin remodelling and thereby may regulate localized concentrations of PtdIns(3,4,5)P 3 .
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MATERIALS AND METHODS

Reagents.
Monoclonal antibodies raised to human platelet filamin, SHIP-1, cortactin, and HA were obtained from Chemicon (Temecula, U.S.A), Santa Cruz (Santa Cruz, U.S.A), Auspep (Parkville, Australia), Molecular Probes (Eugene, U.S.A), and Silenus (Melbourne, Australia). Rabbit polyclonal antibodies to glycocalicin (a soluble fragment of GPIb ) and SHIP-2 were raised as previously described. 6, 18 von Willebrand Factor (vWF) and botrocetin were purified as previously described. 9 [ - 32 P]dCTP and [ -32 P]ATP were from NEN Life Science products (Boston, U.S.A) HA-SHIP-1 cDNA was a kind gift from Dr. Gerry Krystal (British Columbia Cancer Agency, Canada). All other reagents were purchased from Sigma (St. Louis, U.S.A) unless otherwise stated.
Northern Blot Analysis.
A membrane containing approximately 20 µg poly(A) RNA isolated from various cell lines was probed with the C-terminal proline-rich domain of human SHIP-2 cDNA (encompassing nucleotides 3017-3989) labelled with [ -32 P]dCTP by random priming (Prime-a-gene, Promega) and hybridised to the membrane overnight at 42 o C. Blots were washed using standard procedures. 22 The membranes were allowed to decay and subsequently hybridized to an actin probe.
Platelet Immunoprecipitations.
Platelets obtained from healthy volunteers who were medication free for at least ten days were washed using a previously described method. 23 Washed platelets were either not stimulated or stimulated with 1 U/ml of thrombin or vWF, 10 µg/ml, and botrocetin, 3 µg/ml, for 5 minutes. Following activation with thrombin or vWF, the were lysed with 1 volume of Triton X-100 lysis buffer (without EGTA) and fractionated in the presence of DNase I (final concentration of 2 mg/ml). The Triton X-100-soluble fraction was isolated and immunoprecipitated as described above with either non-immune sera, or affinity-purified SHIP-2 antibodies.
Intracellular localization in platelets.
Coverslips were coated with vWF (10 µg/ml) blocked as previously described. 24 Platelets obtained from healthy volunteers as previously described, 23 were applied to vWF -coated coverslips and incubated at 37°C. Following this, coverslips were washed with Tyrodes buffer (12 mM NaHCO 3 , 10 mM Hepes, 137 mM NaCl, 2.7 mM KCl, 5.5 mM glucose), fixed with 4 % formaldehyde and permeabilized with 0.5 % Triton X-100.
Polymerized actin was detected using phalloidin-Texas Red conjugate. Proteins were detected using ployclonal antibodies to; GPIb diluted 1:300 (final concentration of 0.76 µg/ml), GPIb p diluted 1:1000 (final concentration of 0.40 µg/ml), and affinity-purified SHIP-2 used neat, detected with FITC-conjuagted goat anti-rabbit IgG. Filamin, cortactin and vinculin were localized using monoclonal antibodies diluted 1:1000, 1:100 and 1:800, respectively, and detected with FITC/TRITC-conjugated goat anti-mouse IgG.
PtdIns(3,4,5)P 3 5-Phosphatase Assays. Following incubation overnight at room temperature, the reaction was terminated by the addition of 1 M HCl, and following the addition of 5 µg of phosphatidylserine, the lipid was extracted with chloroform/methanol (1:1) and 2 M KCl saturated with chloroform and dried. PtdIns(3,4,5)P 3 5-phosphatase assays were performed on immunoprecipitates in a buffer containing 50 mM Tris, pH 7.2 and 5 mM MgCl 2 as described previously. 26 Following the reaction, lipids were extracted and analyzed by TLC. The phosphoinositide standards used for the migration of PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 on TLC were verified by deacylation and HPLC analysis.
27
Immunoblottting HA-tagged SHIP-2 and SHIP-1 recombinant proteins in COS-1 cells.
COS-1 cells were transiently transfected with either HA empty vector, HA-SHIP-2, or HA-SHIP-1 as previously described 18 and lysates immunoblotted with either affinity-purified polyclonal SHIP-2 antibodies, or monoclonal SHIP-1 antibodies.
RESULTS
SHIP-2 is expressed in platelets
Although SHIP-2 has been strongly implicated in regulating actin dynamics at the leading edge of the cell, this signal-terminating enzyme has not been characterized in highly motile cells, such as platelets. Analysis of the expression profile of SHIP-2, has revealed widespread expression in skeletal muscle, heart, brain, lung and some hematopoietic cells including T and B cells. 20, 28 However, expression of SHIP-2 in
platelets has yet to be fully characterized. Northern analysis was therefore performed To further characterize SHIP-2 in platelets, we immunoblotted and immunoprecipitated SHIP-2 from Triton-soluble platelet lysates using a previously characterized affinity-purified SHIP-2-specific anti-peptide antibody. 18 This SHIP-2 antibody is raised to peptide sequences, unique to SHIP-2, not found in the highly related We also investigated if SHIP-2 translocated to the actin cytoskeleton in thrombinstimulated platelets, as has been shown for SHIP-1. The subcellular compartmentalization of SHIP-2, filamin and GPIb in resting versus thrombin-stimulated platelets was compared to that of the p85 subunit of PI 3-kinase. In unstimulated platelets, SHIP-2 was detected in the Triton-soluble fraction, but not in the actin cytoskeleton ( Figure 1D ).
Minor proteolysis of SHIP-2 was demonstrated by the presence of a slightly faster migrating polypeptide, which we and others have previously detected in various cell lysates. 29 In resting platelets, both filamin and GPIb were present in the unstimulated platelet actin cytoskeleton. Following thrombin activation, the level of SHIP-2 expression in the Triton-soluble fraction remained relatively unchanged and SHIP-2 was only detected very faintly in the actin cytoskeleton ( Figure 1D ). However, we noted increased amounts of GPIb and filamin in the actin cytoskeleton following 5 minutes thrombin stimulation.
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Intracellular localization of SHIP-2 in vWF stimulated platelets.
Many motile cells respond to agonists and chemokines by localized actin remodelling or membrane ruffling (lamellipodia) in the direction of the stimulus. 30 Platelets are terminally differentiated anucleate cells, with a highly specialized cytoskeleton, and the formation of filopodia and lamellipodia in response to platelet activation is well described. We investigated the intracellular localization of SHIP-2 in platelets spreading on a vWF matrix using confocal microscopy. In addition, in order to improve the size of the platelet images and the resolution, high-powered confocal microscopy was performed using 400 x magnification.
The intracellular localization of SHIP-2 in platelets spreading on a vWF matrix was dynamic with respect to specific phases of platelet activation and was different to that we previously reported in resting and EGF-stimulated COS-7 cells. 18 At early phases of platelet adhesion, SHIP-2 staining was intense in small unspread platelets and did not specifically localize to any discernable structure however, staining was absent from the To compare the localization of SHIP-2 with respect to actin in platelets spreading on a vWF matrix, we co-stained for SHIP-2 and polymerized actin, the latter was detected using phalloidin. In partially spread platelets, the staining of SHIP-2 at filopodia co-localized intensely with actin, (see arrow Figure 2Ba and b) and at the central actin ring (also called the granulomere) 31 The intracellular domain of GPIb associates with filamin, which in turn directly binds actin. 5, 8 In resting platelets, this interaction stabilizes the platelet membrane. In addition, under conditions of high shear the interaction between GPIb and filamin is essential for receptor anchorage to vWF matrix. 4, 8 As we have shown SHIP-2 associates with filamin and actin, we determined if GPIb was also present in this complex. This was also of interest, as we have previously shown that PI 3-kinase binds to GPIb via an interaction with 14-3-3, and therefore may generate PtdIns(3,4,5)P 3 , the substrate for SHIP-2, in close association with the receptor. For personal use only. on November 12, 2017. by guest www.bloodjournal.org From vWF mediates platelet adhesion through the binding of matrix-bound vWF to GPIb-IX-V, which then transmits signals leading to platelet activation. We investigated whether the association of SHIP-2 and filamin was also influenced by signaling, specifically mediated through the GPIb-IX-V complex. Anti-SHIP-2 immunoprecipitates from the Triton-soluble fraction of untreated or vWF -stimulated platelets were immunoblotted with filamin or GPIb antibodies ( Figure 4A, lower panels) . These studies demonstrated that SHIP-2 immunoprecipitates contained both filamin and GPIb.
However, following vWF treatment, the level of the SHIP-2/filamin/GPIb complex detected in the Triton-soluble fraction decreased significantly.
To confirm interactions between SHIP-2, filamin and GPIb, reciprocal immunoprecipitation experiments were performed in which filamin was immunoprecipitated from the Triton-soluble fraction, derived from resting or thrombinstimulated platelets, and probed using affinity-purified polyclonal antibodies to SHIP-2 or GPIb ( Figure 4B cytoskeleton and due to the technical constraints of the harsh extraction conditions using RIPA extraction buffer, which contains 1% NP40 and 0.1% SDS, we cannot demonstrate this complex in the activated actin cytoskeleton. Therefore to investigate these species in the activated cytoskeleton, the intracellular localization of SHIP-2, filamin, and GPIb (detected using specific antibodies) was co-localized with actin (detected by phalloidin staining, which stains polymerized actin) in platelets spreading on a vWF matrix ( Figure   5 ). The co-localization of filamin and GPIb with actin in a functional model of spreading platelets to our knowledge has not been previously reported.
In partially spread platelets, filamin localized in the cytosol and plasma membrane staining was prominent (Figure 5Aa ). Patchy co-localization with actin was demonstrated in between filamin and actin at the central actin ring (Figure 5Aa Figure 5B ). We also examined whether GPIb co-localized with filamin ( Figure 5C ). Consistent with the immunoprecipitation data demonstrating decreased detection of the filamin and GPIb complex with platelet activation in the Triton-soluble fraction, patchy co-localization between these species was observed. In spread platelets, filamin localized predominantly at the plasma membrane, whilst the receptor localized to the centre of the platelet. Patchy co-localization was detected at the centre of the spread platelet, with no co-localization detected at the plasma membrane ( Figure 5C ). In control studies, to demonstrate specificity of the antibodies we examined the intracellular localization of vinculin and cortactin. Vinculin localized to the platelet membrane, and diffusely in the cytosol with no staining detected at the central actin ring, whereas cortactin localized to lamellipodia at the plasma membrane, as has recently been reported in platelets ( Figure 5D ). 32 For Figure 5A , B, C and D We also determined the co-localization of SHIP-2 with filamin in spreading platelets ( Figure 6 ). SHIP-2 and filamin co-localized intensely at filopodia and also demonstrated co-localization at the central actin ring (Figure 6a and b) . In spread platelets filamin localized most intensely at the plasma membrane (Figure 6c ). Colocalization between filamin and SHIP-2 was demonstrated at plasma membrane lamellipodia (Figure   6c merged images) . In the cytosol SHIP-2 staining was detected, but filamin staining was less intense and the two species demonstrated only patchy co-localization at this site.
These studies suggest the SHIP-2-filamin complex may be incorporated in to the submembraneous actin cytoskeleton, as platelets are activated by spreading on a vWF matrix.
For Third, SHIP-2 also complexes with GPIb-IX-V and following platelet activation less complex is detected in the Triton-soluble fraction. Fourth, we have also investigated the relationship between SHIP-2/filamin/actin and GPIb-IX-V and co-localized these species by imaging platelets spreading on a vWF matrix. These studies indicate GPIb-IX-V is primarily localized to the centre of the platelet, whilst filamin localizes with SHIP-2 at lamellipodia at the submembrane actin cytoskeleton, suggesting the complex between SHIP-2 and filamin may relocalize to this site, rather than disassociate upon platelet activation.
PtdIns(3,4,5)P 3 is a critical regulator of many intracellular signaling pathways.
Recent studies have highlighted the role this lipid signaling cascade, in particular PtdIns(3,4,5)P 3, plays in instructing actin remodelling. 14, 15, 17 PtdIns ( In human platelets which express high levels of calpain, the decreased association of SHIP-2 with filamin in activated platelets may result from calpain-mediated cleavage of filamin at the hinge region, thereby disrupting the SHIP-2 binding site. Previously we have shown using yeast two-hybrid analysis that the association between SHIP-2 and filamin is maximal when mediated by filamin repeats 22-24, which includes the calpain-cleaved hinge II region, located between repeats 23 and 24 (see Figure 3A) . 18 Repeats 22
and 23 in combination, with or without the hinge region II interacted with SHIP-2, however, this was weaker than with intact repeats 22-24. However, we cannot exclude the possibility that the decreased detection of the complex between SHIP-2 and filamin/GPIb-IX-V reflects the incorporation of this complex from the Triton-soluble fraction into the cytoskeletal fraction. In support of this contention, we have shown using immunoconfocal microscopy that SHIP-2 and filamin, but not GPIb-IX-V, co-localize with each other and submembraneous actin at both filopodia and lamellipodia. of filamin. 37 The sequences of the GPIb receptor that mediate this interaction have recently been shown to encompass residues 570-90, which are also essential for membrane anchorage of the receptor complex under conditions of high shear stress. 10 The results of the study reported here demonstrate filamin may also provide a scaffold for the assembly of signaling proteins, such as SHIP-2, to facilitate signaling via the GPIb-IX-V receptor. We also demonstrated in spread platelets that the filamin and the GPIb-IX-V complex are localized in distinct cytoskeletal compartments; filamin at the submembraneous cytoskeleton and the GPIb-IX-V receptor centralized to the inner central actin ring. This receptor localization is consistent with previous studies using electron microscopy that GPIb-IX-V is located centrally, and although receptor
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From localization with respect to polymerized actin or co-localization with filamin was not demonstrated, receptor centralization was shown to be dependent on an intact actin cytoskeleton. 38 However, in contrast to our findings which show a decrease in the filamin/GPIb-IX-V complex detected in the Triton-soluble fraction of activated platelets, Kovacsovics and Hartwig showed constitutive association between these species by coimmunoprecipitation analysis. 38 The reason for these differences may relate to technical differences in that we did not routinely include DNase-I, which potently inhibits actin polymerization, or phallacidin, which stabilizes existing actin filaments in either the lysis or the immunoprecipitation buffer. The results of our analysis are consistent with the contention that as platelets spread and actin polymerizes, GPIb remains internal to the central actin ring and filamin localizes with SHIP-2 to submembraneous actin, rather than incorporating with a centralized/internalized receptor complex. D. The Triton X-100-soluble fraction of resting, thrombin-(1 U/ml, final concentration for 5 minutes), or vWF-stimulated platelets (10 µg/ml, and botrocetin, 3 µg/ml, final concentration for 5 minutes) was isolated. The Triton X-100-soluble fraction was immunoprecipitated with either Non-immune (Non I) sera, SHIP-2, filamin or GPIb antibodies and immunoblotted with the immunoprecipitating antibody. E. Triton X-100-soluble fractions were isolated from untreated platelets and immunoprecipitated with either Non-immune (Non I) sera, affinity-purified SHIP-2 antibodies, filamin antibodies, or GPIb antibodies. The Triton X-100-soluble fraction was also isolated from thrombin-stimulated (1 U/ml, final concentration for 5 minutes) platelets and immunoprecipiated with either Non-immune (Non I) sera or affinity- Platelets spread on a vWF matrix were fixed, permeabilized, co-stained with filamin antibodies and affinity-purified SHIP-2 antibodies, and visualized by confocal microscopy. Bar, 10 µm.
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